BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33795650)

  • 1. LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma.
    Hou X; Shi X; Zhang W; Li D; Hu L; Yang J; Zhao J; Wei S; Wei X; Ruan X; Zheng X; Gao M
    Cell Death Dis; 2021 Apr; 12(4):347. PubMed ID: 33795650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis.
    Huo N; Cong R; Sun ZJ; Li WC; Zhu X; Xue CY; Chen Z; Ma LY; Chu Z; Han YC; Kang XF; Jia SH; Du N; Kang L; Xu XJ
    Cell Death Dis; 2021 Aug; 12(9):799. PubMed ID: 34404767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
    Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
    Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
    Zheng C; Quan RD; Wu CY; Hu J; Lin BY; Dong XB; Xia EJ; Bhandari A; Zhang XH; Wang OC
    J Cell Mol Med; 2019 Dec; 23(12):7974-7984. PubMed ID: 31568662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
    Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer.
    Shi L; Duan R; Sun Z; Jia Q; Wu W; Wang F; Liu J; Zhang H; Xue X
    Cell Death Differ; 2023 Jun; 30(6):1517-1532. PubMed ID: 37031273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
    Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
    Deng XY; Gan XX; Feng JH; Cai WS; Wang XQ; Shen L; Luo HT; Chen Z; Guo M; Cao J; Shen F; Xu B
    Cell Biochem Funct; 2021 Mar; 39(2):317-325. PubMed ID: 32881051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells.
    Pratheeshkumar P; Siraj AK; Divya SP; Parvathareddy SK; Alobaisi K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c-Myc-mediated glycolysis.
    Han J; Xie C; Liu B; Wang Y; Pang R; Bi W; Sheng R; He G; Kong L; Yu J; Ding Z; Chen L; Jia J; Zhang J; Nie C
    Cancer Sci; 2023 Dec; 114(12):4535-4547. PubMed ID: 37750019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1α-Mediated Telomerase Reverse Transcriptase Activation Inducing Autophagy Through Mammalian Target of Rapamycin Promotes Papillary Thyroid Carcinoma Progression During Hypoxia Stress.
    Song H; Chen X; Jiao Q; Qiu Z; Shen C; Zhang G; Sun Z; Zhang H; Luo QY
    Thyroid; 2021 Feb; 31(2):233-246. PubMed ID: 32772829
    [No Abstract]   [Full Text] [Related]  

  • 12. High iodine effects on the proliferation, apoptosis, and migration of papillary thyroid carcinoma cells as a result of autophagy induced by BRAF kinase.
    Zhang D; Xu X; Li J; Yang X; Sun J; Wu Y; Qiao H
    Biomed Pharmacother; 2019 Dec; 120():109476. PubMed ID: 31563816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFE3 Regulates the Function of the Autophagy-Lysosome Pathway to Drive the Invasion and Metastasis of Papillary Thyroid Carcinoma.
    Lu H; Zhu C; Ruan Y; Fan L; Wei K; Yang Z; Chen Q
    Anal Cell Pathol (Amst); 2021; 2021():3081491. PubMed ID: 34660181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway.
    Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X
    Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer.
    Ban EJ; Kim D; Kim JK; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Kim K
    Endocrinol Metab (Seoul); 2021 Feb; 36(1):96-105. PubMed ID: 33677931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway.
    Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
    J Cell Physiol; 2020 Mar; 235(3):2492-2505. PubMed ID: 31565805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6.
    Gugnoni M; Manicardi V; Torricelli F; Sauta E; Bellazzi R; Manzotti G; Vitale E; de Biase D; Piana S; Ciarrocchi A
    Thyroid; 2021 Feb; 31(2):247-263. PubMed ID: 32495722
    [No Abstract]   [Full Text] [Related]  

  • 19. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
    Gao H; Sun X; Wang H; Zheng Y
    Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.